Mettler-Toledo International Inc. (MTD)
USD 1040.58
(4.3%)
USD 1040.58
(4.3%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.18 Billion USD | -7.74% |
| 2022 | 1.24 Billion USD | 12.9% |
| 2021 | 1.09 Billion USD | 23.35% |
| 2020 | 885.95 Million USD | 8.91% |
| 2019 | 811.97 Million USD | 4.28% |
| 2018 | 770.52 Million USD | 13.45% |
| 2017 | 684.81 Million USD | 14.6% |
| 2016 | 599.98 Million USD | 7.28% |
| 2015 | 554.91 Million USD | 5.17% |
| 2014 | 529.22 Million USD | 6.68% |
| 2013 | 481.64 Million USD | 5.81% |
| 2012 | 457.14 Million USD | 10.84% |
| 2011 | 418.9 Million USD | 14.12% |
| 2010 | 371.12 Million USD | 45.77% |
| 2009 | 290.67 Million USD | -25.89% |
| 2008 | 348.96 Million USD | 16.14% |
| 2007 | 300.46 Million USD | 23.11% |
| 2006 | 251.99 Million USD | -3.5% |
| 2005 | 252.92 Million USD | 22.71% |
| 2004 | 206.12 Million USD | 4.63% |
| 2003 | 192.43 Million USD | -9.94% |
| 2002 | 190.54 Million USD | 28.1% |
| 2001 | 155.4 Million USD | 2.15% |
| 2000 | 164.53 Million USD | 5.74% |
| 1999 | 147.57 Million USD | 15.57% |
| 1998 | 125.55 Million USD | -4.54% |
| 1997 | 102.5 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 279.85 Million USD | -1.06% |
| 2024 Q2 | 296.45 Million USD | 5.68% |
| 2023 Q3 | 309.32 Million USD | -3.61% |
| 2023 Q2 | 320.9 Million USD | 15.07% |
| 2023 FY | - USD | -7.74% |
| 2023 Q4 | 281.77 Million USD | -8.91% |
| 2023 Q1 | 278.87 Million USD | -25.01% |
| 2022 FY | - USD | 12.9% |
| 2022 Q1 | 256.83 Million USD | -21.82% |
| 2022 Q2 | 299.03 Million USD | 16.43% |
| 2022 Q3 | 320.79 Million USD | 7.27% |
| 2022 Q4 | 371.89 Million USD | 15.93% |
| 2021 Q3 | 287.24 Million USD | 6.69% |
| 2021 Q4 | 328.51 Million USD | 14.37% |
| 2021 Q2 | 269.23 Million USD | 21.88% |
| 2021 FY | - USD | 23.35% |
| 2021 Q1 | 220.9 Million USD | -28.19% |
| 2020 Q2 | 189.78 Million USD | 22.63% |
| 2020 Q1 | 154.75 Million USD | -42.22% |
| 2020 FY | - USD | 8.91% |
| 2020 Q3 | 244.43 Million USD | 28.8% |
| 2020 Q4 | 307.61 Million USD | 25.85% |
| 2019 Q4 | 267.84 Million USD | 28.66% |
| 2019 Q3 | 208.17 Million USD | 10.18% |
| 2019 Q2 | 188.93 Million USD | 19.37% |
| 2019 FY | - USD | 4.28% |
| 2019 Q1 | 158.28 Million USD | -40.27% |
| 2018 Q1 | 151.1 Million USD | -33.48% |
| 2018 FY | - USD | 13.45% |
| 2018 Q4 | 264.99 Million USD | 37.5% |
| 2018 Q3 | 192.72 Million USD | 6.68% |
| 2018 Q2 | 180.65 Million USD | 19.55% |
| 2017 Q3 | 170.47 Million USD | 8.42% |
| 2017 Q4 | 227.15 Million USD | 33.25% |
| 2017 FY | - USD | 14.6% |
| 2017 Q2 | 157.24 Million USD | 11.49% |
| 2017 Q1 | 141.03 Million USD | -32.34% |
| 2016 FY | - USD | 7.28% |
| 2016 Q3 | 159.48 Million USD | 23.73% |
| 2016 Q4 | 208.44 Million USD | 30.7% |
| 2016 Q1 | 110.41 Million USD | -41.99% |
| 2016 Q2 | 128.89 Million USD | 16.74% |
| 2015 Q1 | 106.42 Million USD | -42.01% |
| 2015 Q3 | 142.6 Million USD | 12.55% |
| 2015 Q4 | 190.33 Million USD | 33.48% |
| 2015 Q2 | 126.7 Million USD | 19.05% |
| 2015 FY | - USD | 5.17% |
| 2014 Q2 | 120.99 Million USD | 22.15% |
| 2014 Q1 | 99.05 Million USD | -42.71% |
| 2014 FY | - USD | 6.68% |
| 2014 Q4 | 183.53 Million USD | 36.29% |
| 2014 Q3 | 134.67 Million USD | 11.3% |
| 2013 Q1 | 93.54 Million USD | -42.18% |
| 2013 Q4 | 172.89 Million USD | 39.27% |
| 2013 Q3 | 124.13 Million USD | 8.91% |
| 2013 Q2 | 113.98 Million USD | 21.86% |
| 2013 FY | - USD | 5.81% |
| 2012 Q3 | 117.94 Million USD | 17.72% |
| 2012 FY | - USD | 10.84% |
| 2012 Q2 | 100.19 Million USD | 13.52% |
| 2012 Q1 | 88.25 Million USD | -35.87% |
| 2012 Q4 | 161.78 Million USD | 37.17% |
| 2011 Q1 | 79.82 Million USD | -36.71% |
| 2011 FY | - USD | 14.12% |
| 2011 Q4 | 137.61 Million USD | 28.57% |
| 2011 Q3 | 107.03 Million USD | 13.22% |
| 2011 Q2 | 94.53 Million USD | 18.43% |
| 2010 FY | - USD | 45.77% |
| 2010 Q1 | 67.64 Million USD | -37.71% |
| 2010 Q4 | 126.12 Million USD | 34.63% |
| 2010 Q3 | 93.68 Million USD | 7.76% |
| 2010 Q2 | 86.93 Million USD | 28.53% |
| 2009 Q3 | 68.61 Million USD | -0.52% |
| 2009 Q4 | 108.58 Million USD | 58.25% |
| 2009 Q1 | 40.64 Million USD | -64.38% |
| 2009 FY | - USD | -25.89% |
| 2009 Q2 | 68.97 Million USD | 69.7% |
| 2008 Q1 | 67.27 Million USD | -34.28% |
| 2008 FY | - USD | 16.14% |
| 2008 Q3 | 84.16 Million USD | 0.91% |
| 2008 Q2 | 83.4 Million USD | 23.97% |
| 2008 Q4 | 114.12 Million USD | 35.61% |
| 2007 Q4 | 102.37 Million USD | 39.41% |
| 2007 Q3 | 73.43 Million USD | 5.11% |
| 2007 Q2 | 69.86 Million USD | 27.49% |
| 2007 Q1 | 54.79 Million USD | -33.9% |
| 2007 FY | - USD | 23.11% |
| 2006 Q1 | 42.08 Million USD | -43.51% |
| 2006 Q3 | 60.79 Million USD | 4.32% |
| 2006 Q2 | 58.28 Million USD | 38.48% |
| 2006 FY | - USD | -3.5% |
| 2006 Q4 | 82.9 Million USD | 36.36% |
| 2005 Q1 | 41.99 Million USD | -36.65% |
| 2005 FY | - USD | 22.71% |
| 2005 Q3 | 57 Million USD | -28.22% |
| 2005 Q4 | 74.5 Million USD | 30.7% |
| 2005 Q2 | 79.41 Million USD | 89.12% |
| 2004 Q4 | 66.28 Million USD | 39.62% |
| 2004 Q3 | 47.47 Million USD | -10.66% |
| 2004 FY | - USD | 4.63% |
| 2004 Q1 | 39.22 Million USD | -35.44% |
| 2004 Q2 | 53.14 Million USD | 35.49% |
| 2003 Q1 | 36.68 Million USD | -27.43% |
| 2003 FY | - USD | -9.94% |
| 2003 Q4 | 60.33 Million USD | 34.36% |
| 2003 Q3 | 45.96 Million USD | -8.06% |
| 2003 Q2 | 49.45 Million USD | 17.48% |
| 2002 Q3 | 46.89 Million USD | -37.96% |
| 2002 Q1 | 38.52 Million USD | 32.02% |
| 2002 FY | - USD | 28.1% |
| 2002 Q2 | 47.24 Million USD | 98.23% |
| 2002 Q4 | 57.88 Million USD | 22.65% |
| 2001 Q4 | 28.9 Million USD | -34.78% |
| 2001 FY | - USD | 2.15% |
| 2001 Q3 | 44.41 Million USD | -27.71% |
| 2001 Q2 | 46.13 Million USD | 70.83% |
| 2001 Q1 | 35.95 Million USD | -33.25% |
| 2000 Q2 | 40.5 Million USD | 25.89% |
| 2000 FY | - USD | 5.74% |
| 2000 Q4 | 52.08 Million USD | 36.93% |
| 2000 Q3 | 39.12 Million USD | -2.59% |
| 2000 Q1 | 32.08 Million USD | -42.6% |
| 1999 Q4 | 47 Million USD | 49.07% |
| 1999 Q1 | 28.31 Million USD | -24.16% |
| 1999 FY | - USD | 15.57% |
| 1999 Q2 | 35.9 Million USD | 21.58% |
| 1999 Q3 | 36.4 Million USD | 5.63% |
| 1998 Q1 | 24.7 Million USD | 389.66% |
| 1998 Q4 | 38.9 Million USD | -6.33% |
| 1998 Q2 | 31.9 Million USD | 27.78% |
| 1998 FY | - USD | -4.54% |
| 1998 Q3 | 30.3 Million USD | 27.64% |
| 1997 Q3 | 10.8 Million USD | 147.58% |
| 1997 Q2 | -22.7 Million USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| 1997 Q4 | -8.7 Million USD | -180.56% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Agilent Technologies, Inc. | 1.67 Billion USD | 29.448% |
| Charles River Laboratories International, Inc. | 1.03 Billion USD | -14.634% |
| Quest Diagnostics Incorporated | 1.73 Billion USD | 31.688% |
| Danaher Corporation | 7.54 Billion USD | 84.323% |
| Enzo Biochem, Inc. | -8.34 Million USD | 14272.952% |
| IQVIA Holdings Inc. | 3.25 Billion USD | 63.662% |
| Laboratory Corporation of America Holdings | 1.34 Billion USD | 12.32% |
| Qiagen N.V. | 650.58 Million USD | -81.861% |
| Revvity, Inc. | 813.25 Million USD | -45.485% |
| Thermo Fisher Scientific Inc. | 10.8 Billion USD | 89.045% |
| Waters Corporation | 1.02 Billion USD | -15.74% |